Overview

Olopatadine Eye Drops and Allergy Skin Testing

Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
Use of olopatadine ophthalmic solution (eye drops) will decrease allergy skin test reactivity.
Phase:
N/A
Details
Lead Sponsor:
Vanderbilt University Medical Center
Treatments:
Olopatadine Hydrochloride
Ophthalmic Solutions
Pharmaceutical Solutions